SEC Form 4 · accession 0001209191-18-048604
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Aron Marc Knickerbocker
Officer — President & CEO · Director
Period of report
Aug 27, 2018
Accepted (ET)
Aug 28, 2018 · 10:06 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 27, 2018 | M | 500 | $11.14 | A | 195,367 | D | |
| Common Stock | holding | — | — | — | 14,238 | I | By the Aron M. Knickerbocker Revocable Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $11.14 | Aug 27, 2018 | M | 500 | D | — | Aug 21, 2024 | Common Stock | 500 | 35,679 | D |
Explanation of responses
- F1This option is fully vested and immediately exercisable.